Summary. Diabetes mellitus in the adult Chinese hamster is characterized by subnormal pancreatic insulin release in vitro, decreased insulin content, and lack of obesity. The cause of the islet B-cell failure is not clear. We measured insulin, glucagon, and somatostatin release from in vitro perfused pancreases of young (mean age 10 and 20weeks), genetically diabetic animals (subline AC, mean plasma glucose 8.0 and 16.6mmol/1, respectively). Compared to age-and sexmatched normal hamsters (subline M, mean plasma glucose 5.3 mmol/1), the younger diabetic animals had a significantly elevated mean plasma glucose level, but net in vitro pancreatic release of insulin, glucagon, and somatostatin was normal. Pancreatic content of insulin and glucagon was also not significantly different from normal. At age 20 weeks, when the plasma glucose of the diabetic animals was even more elevated, pancreatic content and release of insulin were significantly subnormal, whereas glucagon and somatostatin release were normal, and pancreatic content of glucagon was normal. In a similar group of young (mean age 10 weeks) diabetic animals, non-fasting plasma insulin levels were within the normal range, but the corresponding glucose levels were excessive in most of the animals (13 out of 19). In conclusion, 10-week-old diabetic hamsters show mild hyperglycaemia which cannot be accounted for directly by decreased pancreatic release in response to a glucose plus arginine stimulus in vitro. Decreased ability of the B cell to respond in vivo to hyperglycaemia or peripheral resistance to insulin may contribute to later B-cell failure in the older diabetic hamster.
In the genetically diabetic Chinese hamster, overt diabetes is characterized by subnormal plasma insulin level [1] , subnormal pancreatic insulin content [2] [3] [4] , and subnormal glucose-stimulated insulin release [5] [6] [7] . Obvious obesity is never seen. However, because high plasma insulin levels [8] [9] [10] and hyperphagia [11] have been reported in some young Chinese hamsters before the onset of severe glycosuria, it is possible that they experience a transient, B-cell-exhausting period of insulin resistance and excessive insulin release. To detect any early abnormalities in islet hormone release, we measured insulin, glucagon, and somatostatin release from the pancreases of young, genetically diabetic (subline AC) and normal (subline M) Chinese hamsters aged I0 and 20 weeks. These in vitro results were compared with plasma insulin and glucose levels in non-fasted, 10-week-old diabetic and normal animals.
Materials and methods

Animals
Male, genetically diabetic (subline AC) and normal (subline M) Chinese hamsters [7, 12] were obtained from the Upjohn Company cob ony at Kalamazoo, Michigan, USA. Both sublines had been inbred for 21-24 generations. Subline AC diabetic animals begin to show glycosuria at approximately 7 weeks of age. The youngest hamsters whose pancreas we can consistently perfuse are 6-10weeks old. Therefore animals aged 6-12 and 17-21 weeks were taken for perfusion (mean age 10 and 20weeks). Animals were fed Ralston Purina mouse chow No. 5015 (St. Louis, Missouri, USA) and water ad libiturn. Animals were housed in a temperature-and light-controlled room (light on 06.00-18.00 h).
Procedures
Blood was drawn from the orbital sinus [13] from non-fasted animals, usually between 10.30 and ll.00h, and plasma glucose was determined with a glucose analyzer (Beckman, Fullerton, California, USA). For each animal, single glucose measurements were performed 0-3 days before perfusion. Because plasma insulin levels have not been well characterized in subline AC diabetic animals at the apparently critical 10-week-old stage, we measured non-fasting plasma insulin and glucose levels in 18-19 male and female diabetic and normal hamsters. This reference group of young animals was agematched (age range 6-12weeks, mean age 9.6weeks) with the younger diabetic hamsters from which pancreases were perfused. Pancreas perfusion was performed on non-fasted animals as described previously [5] , except that the total perfusion flow rate was 1.0 ml/min. Also, 1% human serum albumin (Armour Pharmaceuticals, Kankakee, Illinois) and 3% Dextran T-40 (Pharmacia, Piscataway, New Jersey) were used instead of 4% albumin [14] . The combined glucose plus arginine was injected by sidearm syringe (Infusion pump, Model 903, Harvard Apparatus, Millis, Massachusetts, USA) Data are given as mean + SEM; number of animals in parentheses; hormone contents are expressed per g wet weight of pancreas at 0.05 ml/min to deliver a final concentration of glucose (5.6 mmol/1) and arginine (20 mmol/l). After perfusion, pancreases were dissected free from other tissues, rinsed, blotted, weighed, and frozen until extraction in acid-ethanol-Benzamidine for insulin and glucagon content [15] . Immunoreactive insulin was measured by a solid-phase, single-antibody radioimmunoassay [16] using pork insulin as standard [5] . Immunoreactive glucagon was measured by a dextran-charcoal method, modified [17] from Unger and Eisentraut [18] , using Unger 30K or Unger 04A antiserum. These two antisera gave identical results in our assays of glucagon release from the perfused normal rat pancreas in vitro. Somatostatin was measured by a double-antibody radioimmunoassay using Vale's $201 antiserum [19] . Net hormone release was calculated as the 'area under the curve' with subtraction of a constant baseline (mean of hormone release at min -2, -1 and 0) for insulin and somatostatin or subtraction of a declining baseline (straight line from min 1 [mean of min -2, -1, 0] to rain 20 [mean of min 25, 28, 30]) for glucagon.
Statistical analysis
Statistical differences were determined by two-tailed Student's t-test. Plasma glucose levels were compared with other parameters by linear correlation. Results are expressed as mean + SEM.
Results
Mean plasma glucose, body weight, pancreas weight, pancreatic content of insulin, glucagon and net hormone release from the normal and diabetic Chinese hamsters at age 6-12 weeks (mean 10) and 17-21 weeks (mean 20) are shown in The patterns of insulin, glucagon, and somatostatin release in response to glucose plus arginine from the in vitro perfused pancreases of these animals are shown in Figure 1 . Basal release of insulin, glucagon, and somatostatin (mean of rain -5 to 0) was normal at each age. Basal release of insulin was constant, whereas glucagon and somatostatin declined gradually, a characteristic previously observed for glucagon and related to surgical stress to the pancreas [20] . In the normal animals, glucose plus arginine-stimulated insulin release was biphasic (first spike at 6 or 7 min), while glucagon secretion was rapid and followed by a waning period as observed previously [15] . Somatostatin secretion gradually increased during the stimulatory period and was sustained during the 10-min observation period after stopping the stimulus. In the younger diabetic animals, insulin release was not significantly different from normal, while at 20 weeks the diabetic hamsters showed significantly subnormal insulin secretion, which is characteristic of other adult diabetic sublines [15, 21] .
Simultaneous non-fasting plasma insulin and glucose levels were measured in a reference group of 6-12-week-old diabetic and normal hamsters ( Table 2) . The mean glucose level (12.4 + 1.6 retool/l) was not significantly different from the mean plasma glucose of the animals from which pancreases were perfused (8.0 _+ 0.7 mmol/1, p-0.15). Plasma insulin levels in the diabetic animals fell within the range for the normal hamsters, but the corresponding glucose levels were excessive ( > 3 SD above the mean of the normal animals) in 13 out of 19 cases. When expressed as an insulin-toglucose ratio for each animal, 18 of the 19 diabetic animals fell below the mean insulin-to-glucose ratio for normal hamsters (data not shown). 
Discussion
In the present study, 10-week-old diabetic animals showed hyperglycaemia in the presence of normal plasma insulin levels and normal in vitro pancreatic insulin release. These data suggest a decreased ability of the B cells in diabetic hamsters to respond in vivo to hyperglycaemia. Perhaps some humoral factor blocks increased insulin release in vivo. Alternatively, the tendency (not-statistically-significant, p-0.07) toward decreased pancreatic insulin content suggests that decreased pancreatic insulin synthesis or storage is responsible for the decreased insulin release. Peripheral resistance to insulin is suggested by the excessive plasma glucose levels in the presence of normal plasma insulin levels. In the present study, we found no evidence of excessive pancreatic insulin release in vitro as is seen in the db/db mouse [22] or as suggested by the hyperinsulinaemia seen in 2-week-old prediabetic hamsters [9] . Possibly 10 weeks is too late to see any excessive insulin secretion, and the fall in pancreatic insulin content is the earliest manifestation of B-cell exhaustion and precedes any observable defect in insulin release in vitro.
To detect possible defects in both insulin and glucagon release, we used a 'low' glucose (5.6 mmol/1) plus 'high' arginine (20 mmol/1) combination. A 'high' glucose challenge might have uncovered a defect in vitro in the younger diabetic animals' response, which is specific to glucose.
The diabetic pancreases showed normal glucagon content and release at age 10 and 20 weeks. Older ACsubline diabetic hamsters showed clearly elevated pancreatic glucagon levels and somewhat elevated plasma glucagon levels [7] . Excessive glucagon release from the perfused pancreas in vitro is a characteristic in some, but not all, diabetic sublines [23] and from the present data, the excessive glucagon release appears to develop later than the insulin secretory defect.
The combination of glucose plus arginine caused a slowly increasing release of somatostatin (with no first phase) in both normal and diabetic pancreases. After stopping the stimulus, somatostatin release did not return to baseline within 10 min as insulin and glucagon release usually do. In fact, somatostatin release showed an overshoot or "off response" in some cases. Since somtatostatin release was not significantly different in the normal and diabetic pancreases, it seems unlikely that somatostatin plays a primary role in the early diabetes of AC subline of Chinese hamsters.
Obesity, insulin resistance, and excessive insulin secretion precede B-cell exhaustion and subnormal insulin release in C57BLKsJ db/db mice [22] . In those mice, restriction of food intake at an early age partially prevented the obesity, postponed the pancreatic B-cell impairment, and postponed the early death characteristic of the animals [24 and O. Berglund, personal communication]. Similarly, restriction of food intake in prediabetic Chinese hamsters for 150 days reduce the severity of subsequent glycosuria and ketonuria [25] . Therefore, early hyperphagia may contribute to later insulin resistance and pancreatic impairment.
In a previous study we treated prediabetic Chinese hamsters with exogenous insulin by continuous infusion in vivo for 1 month [21] . The insulin dosage was sufficient to increase blood insulin levels but did not cause significant lowering of plasma glucose. However, the insulin-treated prediabetics gained slightly more weight and later developed more severe glycosuria than their saline-treated prediabetic siblings. These results suggest that increased circulating insulin promotes insulin resistance and contributes to later pancreatic exhaustion, possibly by increasing body weight (primarily fat) [25] and decreasing insulin receptors.
In conclusion, the present study shows that pancreatic insulin, glucagon, and somatostatin release in vitro are normal in the young diabetic (subline AC) Chinese hamster. Early hyperglycaemia in the presence of "normal" plasma insulin levels and a tendency toward decreased pancreatic insulin levels suggest that the diabetic B cell may begin to fail before the age of 10 weeks with no "hyperinsulin" secretion observable in vitro at age 10 or 20 weeks. Abnormalities in glucagon and somatostatin release do not appear in 10-or 20-week-old subline AC diabetic hamsters. These data do not rule out the possibility that non-islet factors may contribute to insulin resistance and later B-cell failure.
